{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T10:05:36Z","timestamp":1764842736957,"version":"3.37.3"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T00:00:00Z","timestamp":1683590400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T00:00:00Z","timestamp":1683590400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Atheroscler Rep"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s11883-023-01102-5","type":"journal-article","created":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T00:08:18Z","timestamp":1683763698000},"page":"299-307","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Lipoprotein (a): Does It Play a Role in Pediatric Ischemic Stroke and Thrombosis?"],"prefix":"10.1007","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7356-4910","authenticated-orcid":false,"given":"Marcela","family":"Torres","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allyson","family":"Schenk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,9]]},"reference":[{"key":"1102_CR1","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1016\/j.jacc.2009.10.080","volume":"55","author":"S Erqou","year":"2010","unstructured":"Erqou S, Thompson A, Di Angelantonio E, Saleheen D, Kaptoge S, Marcovina S, et al. Apolipoprotein(a) isoforms and the risk of vascular disease. J Am Coll Cardiol. 2010;55:2160\u20137. https:\/\/doi.org\/10.1016\/j.jacc.2009.10.080.","journal-title":"J Am Coll Cardiol"},{"key":"1102_CR2","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/joim.12187","volume":"276","author":"JC Hopewell","year":"2014","unstructured":"Hopewell JC, Seedorf U, Farrall M, Parish S, Kyriakou T, Goel A, et al. Impact of lipoprotein(a) levels and apolipoprotein(a) isoform size on risk of coronary heart disease. J Intern Med. 2014;276:260\u20138. https:\/\/doi.org\/10.1111\/joim.12187.","journal-title":"J Intern Med"},{"key":"1102_CR3","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/j.1365-2796.2012.02592.x","volume":"273","author":"F Kronenberg","year":"2012","unstructured":"Kronenberg F, Utermann G. Lipoprotein(a): resurrected by genetics. J Intern Med. 2012;273:6\u201330. https:\/\/doi.org\/10.1111\/j.1365-2796.2012.02592.x.","journal-title":"J Intern Med"},{"key":"1102_CR4","doi-asserted-by":"publisher","first-page":"3364","DOI":"10.1182\/blood.V96.10.3364.h8003364_3364_3368","volume":"96","author":"M von Depka","year":"2000","unstructured":"von Depka M, Nowak-G\u00f6ttl U, Eisert R, Dieterich C, Barthels M, Scharrer I, et al. Increased lipoprotein (a) levels as an independent risk factor for venous thromboembolism. Blood. 2000;96:3364\u20138. https:\/\/doi.org\/10.1182\/blood.V96.10.3364.h8003364_3364_3368.","journal-title":"Blood"},{"key":"1102_CR5","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1001\/archinte.162.10.1182","volume":"162","author":"AW Tsai","year":"2002","unstructured":"Tsai AW, Cushman M, Rosamond WD, Heckbert SR, Polak JF, Folsom AR. Cardiovascular risk factors and venous thromboembolism incidence: The longitudinal investigation of thromboembolism etiology. Arch Intern Med. 2002;162:1182\u20139. https:\/\/doi.org\/10.1001\/archinte.162.10.1182.","journal-title":"Arch Intern Med"},{"key":"1102_CR6","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1161\/CIRCULATIONAHA.109.913673","volume":"121","author":"G Kenet","year":"2010","unstructured":"Kenet G, L\u00fctkhoff LK, Albisetti M, Bernard T, Bonduel M, Brandao L, et al. Impact of thrombophilia on risk of arterial ischemic stroke or cerebral sinovenous thrombosis in neonates and children: A systematic review and meta-analysis of observational studies. Circulation. 2010;121:1838\u201347. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.913673.","journal-title":"Circulation"},{"key":"1102_CR7","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1161\/STR.0000000000000183","volume":"50","author":"D Ferriero","year":"2019","unstructured":"Ferriero D, Fullerton H, Bernard T, Billinghurst L, Daniels S, DeBaun M, et al. Management of stroke in neonates and children: A scientific statement from the American heart association\/American stroke association. Stroke. 2019;50:e51-96. https:\/\/doi.org\/10.1161\/STR.0000000000000183.","journal-title":"Stroke"},{"key":"1102_CR8","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1161\/01.CIR.100.7.743","volume":"100","author":"U Nowak-Gottl","year":"1999","unstructured":"Nowak-Gottl U, Junker R, Hartmeier M, Koch H, Munchow N, Assmann G, et al. Increased lipoprotein(a) is an important risk factor for venous thromboembolism in childhood. Circulation. 1999;100:743\u20138. https:\/\/doi.org\/10.1161\/01.CIR.100.7.743.","journal-title":"Circulation"},{"key":"1102_CR9","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1161\/CIRCULATIONAHA.108.789008","volume":"118","author":"G Young","year":"2008","unstructured":"Young G, Albisetti M, Bonduel M, Brandao L, Chan A, Friedrichs F, et al. Impact of inherited thrombophilia on venous thromboembolism in children: A systematic review and meta-analysis of observational studies. Circulation. 2008;118:1373\u201382. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.108.789008.","journal-title":"Circulation"},{"key":"1102_CR10","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.metabol.2012.07.024","volume":"62","author":"J Hoover-Plow","year":"2013","unstructured":"Hoover-Plow J, Huang M. Lipoprotein(a) metabolism: Potential sites for therapeutic targets. Metabolism. 2013;62:479\u201391. https:\/\/doi.org\/10.1016\/j.metabol.2012.07.024.","journal-title":"Metabolism"},{"key":"1102_CR11","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1172\/JCI115855","volume":"90","author":"E Boerwinkle","year":"1992","unstructured":"Boerwinkle E, Leffert CC, Lin J, Lackner C, Chiesa G, Hobbs HH. Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. J Clin Invest. 1992;90:52\u201360. https:\/\/doi.org\/10.1172\/JCI115855.","journal-title":"J Clin Invest"},{"key":"1102_CR12","doi-asserted-by":"publisher","first-page":"S57","DOI":"10.1016\/j.jacl.2015.07.006","volume":"9","author":"CJ McNeal","year":"2015","unstructured":"McNeal CJ. Lipoprotein(a): Its relevance to the pediatric population. J Lipid Res. 2015;9:S57-66. https:\/\/doi.org\/10.1016\/j.jacl.2015.07.006.","journal-title":"J Lipid Res"},{"key":"1102_CR13","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/MOL.0000000000000753","volume":"32","author":"G Reyes-Soffer","year":"2021","unstructured":"Reyes-Soffer G. The impact of race and ethnicity on lipoprotein(a) levels and cardiovascular risk. Curr Opin Lipidol. 2021;32:163\u20136. https:\/\/doi.org\/10.1097\/MOL.0000000000000753.","journal-title":"Curr Opin Lipidol"},{"key":"1102_CR14","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1161\/ATVBAHA.112.251306","volume":"32","author":"DS Spence","year":"2012","unstructured":"Spence DS, Koschinsky M. Mechanisms of lipoprotein(a) pathogenicity: Prothrombotic, proatherosclerotic, or both? Arterioscler Thromb Vasc Biol. 2012;32:1550\u20131. https:\/\/doi.org\/10.1161\/ATVBAHA.112.251306.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1102_CR15","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/j.jacc.2022.07.027","volume":"80","author":"P Lacaze","year":"2022","unstructured":"Lacaze P, Bakshi A, Riaz M, Polekhina G, Owen A, Bhatia HS, et al. Aspirin for primary prevention of cardiovascular events in relation to lipoprotein genotypes. J Am Coll Cardiol. 2022;80:1287\u201398. https:\/\/doi.org\/10.1016\/j.jacc.2022.07.027.","journal-title":"J Am Coll Cardiol"},{"key":"1102_CR16","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/339303a0","volume":"339","author":"KA Hajjar","year":"1989","unstructured":"Hajjar KA, Gavishi D, Breslow JL, Nachman RL. Lipoprotein( a ) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis. Nature. 1989;339:303\u20135. https:\/\/doi.org\/10.1038\/339303a0.","journal-title":"Nature"},{"key":"1102_CR17","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/339301a0","volume":"339","author":"LA Miles","year":"1989","unstructured":"Miles LA, Fless GM, Levin EG, Scanu AM, Plow EF. A potential basis for the thrombotic risks associated with lipoprotein( a ). Nature. 1989;339:301\u20133. https:\/\/doi.org\/10.1038\/339301a0.","journal-title":"Nature"},{"key":"1102_CR18","doi-asserted-by":"publisher","first-page":"3847","DOI":"10.1073\/pnas.86.10.3847","volume":"3","author":"PC Harpel","year":"1989","unstructured":"Harpel PC, Gordon BR, Parker TS. Plasmin catalyzes binding of lipoprotein (a) to immobilized fibrinogen and fibrin. Fibrinolysis. 1989;3:3847\u201351. https:\/\/doi.org\/10.1073\/pnas.86.10.3847.","journal-title":"Fibrinolysis"},{"key":"1102_CR19","doi-asserted-by":"publisher","first-page":"4628","DOI":"10.1021\/bi00068a021","volume":"32","author":"A Ezratty","year":"1993","unstructured":"Ezratty A, Simon DI, Loscalzo J. Lipoprotein(a) binds to human platelets and attenuates plasminogen binding and activation. Biochemistry. 1993;32:4628\u201333. https:\/\/doi.org\/10.1021\/bi00068a021.","journal-title":"Biochemistry"},{"key":"1102_CR20","doi-asserted-by":"publisher","first-page":"5151","DOI":"10.1021\/bi00015a028","volume":"34","author":"W Sangrar","year":"1995","unstructured":"Sangrar W, Bajzar L, Nesheim ME, Koschinsky ML. Antifibrinolytic effect of recombinant apolipoprotein(a) in vitro is primarily due to attenuation of tPA-mediated glu-plasminogen activation. Biochemistry. 1995;34:5151\u20137. https:\/\/doi.org\/10.1021\/bi00015a028.","journal-title":"Biochemistry"},{"key":"1102_CR21","doi-asserted-by":"publisher","first-page":"23260","DOI":"10.1074\/jbc.M302780200","volume":"278","author":"MA Hancock","year":"2003","unstructured":"Hancock MA, Boffa MB, Marcovina SM, Nesheim ME, Koschinsky ML. Inhibition of plasminogen activation by lipoprotein(a). J Biol Chem. 2003;278:23260\u20139. https:\/\/doi.org\/10.1074\/jbc.M302780200.","journal-title":"J Biol Chem"},{"key":"1102_CR22","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1194\/jlr.M036566","volume":"55","author":"R Romagnuolo","year":"2014","unstructured":"Romagnuolo R, Marcovina SM, Boffa MB, Koschinsky ML. Inhibition of plasminogen activation by apo(a): Role of carboxyl-terminal lysines and identification of inhibitory domains in apo(a)[S]. J Lipid Res. 2014;55:625\u201334. https:\/\/doi.org\/10.1194\/jlr.M036566.","journal-title":"J Lipid Res"},{"key":"1102_CR23","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.atherosclerosis.2018.05.029","volume":"275","author":"R Romagnuolo","year":"2018","unstructured":"Romagnuolo R, Scipione CA, Bazzi ZA, Boffa MB, Koschinsky ML. Inhibition of pericellular plasminogen activation by apolipoprotein(a): Roles of urokinase plasminogen activator receptor and integrins \u03b1M\u03b22 and \u03b1V\u03b23. Atherosclerosis. 2018;275:11\u201321. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.05.029.","journal-title":"Atherosclerosis"},{"key":"1102_CR24","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/nm0395-256","volume":"1","author":"TM Palabrica","year":"1995","unstructured":"Palabrica TM, Liu AC, Aronovitz MJ, Furie B, Lawn RM, Furie BC. Antifibrinolytic activity of apolipoprotein(a) in vivo\u202f: Human apolipoprotein(a) transgenic mice are resistant to tissue plasminogen activator-mediated thrombolysis. Nat Med. 1995;1:256\u20139. https:\/\/doi.org\/10.1038\/nm0395-256.","journal-title":"Nat Med"},{"key":"1102_CR25","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1194\/jlr.P094763","volume":"60","author":"MB Boffa","year":"2019","unstructured":"Boffa MB, Marar TT, Yeang C, Viney NJ, Xia S, Witztum JL, et al. Potent reduction of plasma lipoprotein (a) with an antisense oligonucleotide in human subjects does not affect ex vivo fibrinolysis. J Lipid Res. 2019;60:2082\u20139. https:\/\/doi.org\/10.1194\/jlr.P094763.","journal-title":"J Lipid Res"},{"key":"1102_CR26","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/jth.12056","volume":"11","author":"JS Danik","year":"2012","unstructured":"Danik JS, Buring JE, Chasman DI, Zee RYL, Ridker PM, Glynn RJ. Lipoprotein(a), polymorphisms in the LPA gene, and incident venous thromboembolism among 21 483 women. J Thomb Haemost. 2012;11:205\u20138. https:\/\/doi.org\/10.1111\/jth.12056.","journal-title":"J Thomb Haemost"},{"key":"1102_CR27","doi-asserted-by":"publisher","first-page":"802","DOI":"10.3324\/haematol.2012.073833","volume":"98","author":"NA Goldenberg","year":"2013","unstructured":"\u2022 Goldenberg NA, Bernard TJ, Hillhouse J, Armstrong-Wells J, Galinkin J, Knapp-Clevenger R, et al. Elevated lipoprotein (a), small apolipoprotein (a), and the risk of arterial ischemic stroke in north american children. Haematologica. 2013;98:802\u20137. https:\/\/doi.org\/10.3324\/haematol.2012.073833. First study looking into risk of incident cases of pediatric arterial ischemic stroke in relation to lipoprotein (a) and apolipoprotein(a) race specific percentile levels. No correlation found but risk of recurrence was higher in cases with >90 percentile lipoprotein (a) and apolipoprotein(a)<10 percentile levels.","journal-title":"Haematologica"},{"key":"1102_CR28","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1093\/eurheartj\/ehab251","volume":"42","author":"S Tsimikas","year":"2021","unstructured":"\u2022\u2022 Tsimikas S. Elevated lipoprotein(a) and the risk of stroke in children, young adults, and the elderly. Eur Heart J. 2021;42:2197\u2013200. https:\/\/doi.org\/10.1093\/eurheartj\/ehab251. This article is the first to suggest that the proatherogenic, antifibrinolytic, and pro-inflammatory properties of lipoprotein(a) may vary by age group. Therefore, the role of lipoprotein(a) in pathogenesis of stroke and thrombosis, may be completely different between children and adults.","journal-title":"Eur Heart J"},{"key":"1102_CR29","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1001\/jamaneurol.2022.2077","volume":"79","author":"SN Poisson","year":"2022","unstructured":"\u2022 Poisson SN, Hills NK, Sidney S, Fullerton HJ. Prevalence of atherosclerotic risk factors among children and young adults with arterial ischemic stroke. JAMA Neurol. 2022;79:901\u201310. https:\/\/doi.org\/10.1001\/jamaneurol.2022.2077. This study provides evidence that lipoprotein(a) does not become proatherogenic until later in life and suggests that the potential relationship between elevated lipoprotein(a) and pediatric stroke must occur via a different mechanism.","journal-title":"JAMA Neurol"},{"key":"1102_CR30","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1159\/000518281","volume":"55","author":"DM Oleske","year":"2021","unstructured":"Oleske DM, Cheng X, Jeong A, Arndt TJ. Pediatric acute ischemic stroke by age-group: A systematic review and meta-analysis of published studies and hospitalization records. Neuroepidemiology. 2021;55:331\u201341. https:\/\/doi.org\/10.1159\/000518281.","journal-title":"Neuroepidemiology"},{"key":"1102_CR31","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.pediatrneurol.2017.01.016","volume":"69","author":"GA deVeber","year":"2017","unstructured":"deVeber GA, Kirton A, Booth FA, Yager JY, Wirrell EC, Wood E, et al. Epidemiology and outcomes of arterial ischemic stroke in children: The canadian pediatric ischemic stroke registry. Pediatr Neurol. 2017;69:58\u201370. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2017.01.016.","journal-title":"Pediatr Neurol"},{"key":"1102_CR32","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1161\/01.STR.31.10.2437","volume":"31","author":"G Gunther","year":"2000","unstructured":"Gunther G, Junker R, Strater R, Schobess R, Kurnik K, Kosch A, et al. Symptomatic ischemic stroke in full-term neonates: Role of acquired and genetic prothrombotic risk factors. Stroke. 2000;31:2437\u201341. https:\/\/doi.org\/10.1161\/01.STR.31.10.2437.","journal-title":"Stroke"},{"key":"1102_CR33","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1177\/0883073811435238","volume":"27","author":"E Merlin","year":"2012","unstructured":"Merlin E, Dor\u00e9 E, Chabrier S, Biard M, Marques-Verdier A, St\u00e9phan J. A case of infantile de novo primary antiphospholipid syndrome revealed by a neonatal arterial ischemic stroke. J Child Neurol. 2012;27:1340\u20132. https:\/\/doi.org\/10.1177\/0883073811435238.","journal-title":"J Child Neurol"},{"key":"1102_CR34","doi-asserted-by":"publisher","first-page":"71","DOI":"10.24953\/turkjped.2017.01.012","volume":"59","author":"\u00d6 Turan","year":"2017","unstructured":"Turan \u00d6, Anuk-\u0130nce D, Olcay L, Sezer T, G\u00fcllero\u011flu K, Y\u0131lmaz-\u00c7elik Z, et al. Neonatal cerebral sinovenous thrombosis: Two cases, two different gene polymorphisms and risk factors. Turk J Pediatr. 2017;59:71\u20135. https:\/\/doi.org\/10.24953\/turkjped.2017.01.012.","journal-title":"Turk J Pediatr"},{"key":"1102_CR35","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.braindev.2011.04.003","volume":"34","author":"C Kocaman","year":"2011","unstructured":"Kocaman C, Yilmaz Y. Etiological analysis of presumed perinatal stroke. Brain Dev. 2011;34:133\u20139. https:\/\/doi.org\/10.1016\/j.braindev.2011.04.003.","journal-title":"Brain Dev"},{"key":"1102_CR36","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S1474-4422(13)70290-4","volume":"13","author":"AA Mallick","year":"2014","unstructured":"Mallick AA, Ganesan V, Kirkham FJ, Fallon P, Hedderly T, McShane T, et al. Childhood arterial ischaemic stroke incidence, presenting features, and risk factors: A prospective population-based study. Lancet Neurol. 2014;13:35\u201343. https:\/\/doi.org\/10.1016\/S1474-4422(13)70290-4.","journal-title":"Lancet Neurol"},{"key":"1102_CR37","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1177\/1076029609334124","volume":"16","author":"S Teber","year":"2010","unstructured":"Teber S, Deda G, Akar N, Soylu K. Lipoprotein (a) levels in childhood arterial ischemic stroke. Clin Appl Thromb Hemost. 2010;16:214\u20137. https:\/\/doi.org\/10.1177\/1076029609334124.","journal-title":"Clin Appl Thromb Hemost"},{"key":"1102_CR38","doi-asserted-by":"publisher","first-page":"3678","DOI":"10.1182\/blood.V94.11.3678","volume":"94","author":"U Nowak-G\u00f6ttl","year":"1999","unstructured":"Nowak-G\u00f6ttl U, Str\u00e4ter R, Heinecke A, Junker R, Koch H, Schuierer G, et al. Lipoprotein (a) and genetic polymorphisms of clotting factor V, prothrombin, and methylenetetrahydrofolate reductase are risk factors of spontaneous ischemic stroke in childhood. Blood. 1999;94:3678\u201382. https:\/\/doi.org\/10.1182\/blood.V94.11.3678.","journal-title":"Blood"},{"key":"1102_CR39","doi-asserted-by":"publisher","first-page":"S122","DOI":"10.1007\/PL00014336","volume":"158 Suppl 3","author":"R Str\u00e4ter","year":"1999","unstructured":"Str\u00e4ter R, Vielhaber H, Kassenb\u00f6hmer R, von Kries R, G\u00f6bel U, Nowak-G\u00f6ttl U. Genetic risk factors of thrombophilia in ischaemic childhood stroke of cardiac origin. A prospective ESPED survey. Eur J Pediatr. 1999;158 Suppl 3:S122-5. https:\/\/doi.org\/10.1007\/PL00014336.","journal-title":"Eur J Pediatr"},{"key":"1102_CR40","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1182\/blood.V83.5.1251.1251","volume":"83","author":"M Andrew","year":"1994","unstructured":"Andrew M, David M, Grant R, Israels S, Jardine L, Luke B, et al. Venous thromboembolic complications (VTE) in children: First analyses of the canadian registry of VTE. Blood. 1994;83:1251\u20137. https:\/\/doi.org\/10.1182\/blood.V83.5.1251.1251.","journal-title":"Blood"},{"key":"1102_CR41","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1182\/blood-2016-11-750893","volume":"129","author":"C Curtis","year":"2017","unstructured":"Curtis C, Mineyko A, Massicotte P, Leaker M, Jiang XY, Floer A, et al. Thrombophilia risk is not increased in children after perinatal stroke. Blood. 2017;129:2793\u2013800. https:\/\/doi.org\/10.1182\/blood-2016-11-750893.","journal-title":"Blood"},{"key":"1102_CR42","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/ijs.12136","volume":"9","author":"SM Sultan","year":"2014","unstructured":"Sultan SM, Schupf N, Dowling MM, DeVeber GA, Kirton A, Elkind MSV. Review of lipid and lipoprotein(a) abnormalities in childhood arterial ischemic stroke. Int J Stroke. 2014;9:79\u201387. https:\/\/doi.org\/10.1111\/ijs.12136.","journal-title":"Int J Stroke"},{"key":"1102_CR43","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1016\/S0022-2275(20)37461-7","volume":"37","author":"SM Marcovina","year":"1996","unstructured":"Marcovina SM, Albers JJ, Wijsman E, Zhang Z, Chapman NH, Kennedy H. Differences in lp[a] concentrations and apo[a] polymorphs between black and white americans. J Lipid Res. 1996;37:2569\u201385. https:\/\/doi.org\/10.1016\/S0022-2275(20)37461-7.","journal-title":"J Lipid Res"},{"key":"1102_CR44","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1067\/mpd.2001.118192","volume":"139","author":"CH van Ommen","year":"2001","unstructured":"van Ommen CH, Heijboer H, B\u00fcller HR, Hirasing RA, Heijmans HSA, Peters M. Venous thromboembolism in childhood: A prospective two-year registry in the netherlands. J Pediatr. 2001;139:676\u201381. https:\/\/doi.org\/10.1067\/mpd.2001.118192.","journal-title":"J Pediatr"},{"key":"1102_CR45","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1161\/01.CIR.0000087598.05977.45","volume":"108","author":"C Heller","year":"2003","unstructured":"Heller C, Heinecke A, Junker R, Knofler R, Kosch A, Kurnik K, et al. Cerebral venous thrombosis in children: A multifactorial origin. Circulation. 2003;108:1362\u20137. https:\/\/doi.org\/10.1161\/01.CIR.0000087598.05977.45.","journal-title":"Circulation"},{"key":"1102_CR46","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1016\/j.jocn.2013.10.030","volume":"21","author":"R Konanki","year":"2014","unstructured":"Konanki R, Gulati S, Saxena R, Gupta AK, Seith A, Kumar A, et al. Profile of prothrombotic factors in indian children with ischemic stroke. J Clin Neurosci. 2014;21:1315\u20138. https:\/\/doi.org\/10.1016\/j.jocn.2013.10.030.","journal-title":"J Clin Neurosci"},{"key":"1102_CR47","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.24953\/turkjped.2021.06.011","volume":"63","author":"YD Kar","year":"2021","unstructured":"Kar YD, \u00d6zdemir ZC, \u00c7arman KB, Yarar C, Tekin N, B\u00f6r \u00d6. Cerebral sinovenous thrombosis in children: Clinical presentation, locations, and acquired and inherited prothrombotic risk factors. Turk J Pediatr. 2021;63:1028\u201337. https:\/\/doi.org\/10.24953\/turkjped.2021.06.011.","journal-title":"Turk J Pediatr"},{"key":"1102_CR48","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1111\/jth.12699","volume":"12","author":"K Thom","year":"2014","unstructured":"Thom K, Male C, Mannhalter C, Quehenberger P, Mlczoch E, Luckner D, et al. No impact of endogenous prothrombotic conditions on the risk of central venous line-related thrombotic events in children: Results of the KIDCAT study (KIDs with catheter associated thrombosis). J Thromb Haemost. 2014;12:1610\u20135. https:\/\/doi.org\/10.1111\/jth.12699.","journal-title":"J Thromb Haemost"},{"key":"1102_CR49","doi-asserted-by":"publisher","first-page":"e26938","DOI":"10.1002\/pbc.26938","volume":"65","author":"UH Athale","year":"2018","unstructured":"Athale UH, Mizrahi T, Laverdi\u00e8re C, Nayiager T, Delva Y\u2010, Foster G, et al. Impact of baseline clinical and laboratory features on the risk of thrombosis in children with acute lymphoblastic leukemia: A prospective evaluation. Pediatr Blood Cancer. 2018;65:e26938. https:\/\/doi.org\/10.1002\/pbc.26938.","journal-title":"Pediatr Blood Cancer."},{"key":"1102_CR50","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1161\/STROKEAHA.117.017356","volume":"48","author":"LL Lehman","year":"2017","unstructured":"Lehman LL, Beaute J, Kapur K, Danehy AR, Bernson-Leung ME, Malkin H, et al. Workup for perinatal stroke does not predict recurrence. Stroke. 2017;48:2078\u201383. https:\/\/doi.org\/10.1161\/STROKEAHA.117.017356.","journal-title":"Stroke"},{"key":"1102_CR51","doi-asserted-by":"publisher","unstructured":"Fullerton HJ, Elkind MSV, Barkovich AJ, Glaser C, Glidden D, Hills NK, et al. The vascular effects of infection in pediatric stroke (VIPS) study. J Child Neurol. 2011;26. https:\/\/doi.org\/10.1177\/0883073811408089.","DOI":"10.1177\/0883073811408089"},{"key":"1102_CR52","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.pediatrneurol.2017.09.019","volume":"78","author":"S Sultan","year":"2018","unstructured":"Sultan S, Dowling M, Kirton A, DeVeber G, Linds A, Elkind MSV, et al. Dyslipidemia in children with arterial ischemic stroke: Prevalence and risk factors. Pediatr Neurol. 2018;78:46\u201354. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2017.09.019.","journal-title":"Pediatr Neurol"},{"key":"1102_CR53","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.3324\/haematol.2019.234666","volume":"104","author":"G deVeber","year":"2019","unstructured":"\u2022\u2022 deVeber G, Kirkham F, Shannon K, Brand\u00e3o L, Str\u00e4ter R, Kenet G, et al. Recurrent stroke: The role of thrombophilia in a large international pediatric stroke population. Haematologica. 2019;104:2116. https:\/\/doi.org\/10.3324\/haematol.2019.234666. Study of thrombophilia risk factors in recurrence of pediatric stroke with data pooled from Canada, Germany and UK showing that after adjusting for vasculopathy, isolated elevated lipoprotein (a) was independently associated with an increased risk of recurrence.","journal-title":"Haematologica"},{"key":"1102_CR54","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.05.013","volume":"23","author":"S Sultan","year":"2014","unstructured":"Sultan S, Schupf N, Dowling M, DeVeber G, Kirton A, Elkind MSV. Predictors of cholesterol and lipoprotein(a) testing in children with arterial ischemic stroke. J Stroke Cerebrovasc Dis. 2014;23:2405\u201313. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2014.05.013.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"1102_CR55","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1542\/peds.2009-2107C","volume":"128","author":"Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents, & National Heart, Lung, and Blood Institute","year":"2011","unstructured":"Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents, & National Heart, Lung, and Blood Institute. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: Summary report. Pediatrics. 2011;128:213. https:\/\/doi.org\/10.1542\/peds.2009-2107C.","journal-title":"Pediatrics"},{"key":"1102_CR56","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/0021-9150(92)90271-H","volume":"92","author":"N Rifai","year":"1992","unstructured":"Rifai N, Heiss G, Doetsch K. Lipoprotein(a) at birth, in blacks and whites. Atherosclerosis. 1992;92:123\u20139. https:\/\/doi.org\/10.1016\/0021-9150(92)90271-H.","journal-title":"Atherosclerosis"},{"key":"1102_CR57","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.jacl.2015.09.002","volume":"9","author":"TA Jacobson","year":"2015","unstructured":"Jacobson TA, Maki KC, Orringer CE, Jones PH, Kris-Etherton P, Sikand G, et al. National lipid association recommendations for patient-centered management of dyslipidemia: Part 2. J Clin Lipid. 2015;9:S1\u2013122. https:\/\/doi.org\/10.1016\/j.jacl.2015.09.002.","journal-title":"J Clin Lipid"},{"key":"1102_CR58","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.jacl.2019.04.010","volume":"13","author":"DP Wilson","year":"2019","unstructured":"\u2022 Wilson DP, Jacobson TA, Jones PH, Koschinsky ML, McNeal CJ, Nordestgaard BG, et al. Use of lipoprotein(a) in clinical practice: A biomarker whose time has come. A scientific statement from the national lipid association. J Lipid Res. 2019;13:374\u201392. https:\/\/doi.org\/10.1016\/j.jacl.2019.04.010. Paper compares the different management recommendations for children (youth) with elevated lipoprotein(a) given by different organizations.","journal-title":"J Lipid Res."},{"key":"1102_CR59","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","volume":"25","author":"F Mach","year":"2020","unstructured":"Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, et al. 2019 ESC\/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;25:111\u201388. https:\/\/doi.org\/10.1093\/eurheartj\/ehz455.","journal-title":"Eur Heart J"},{"key":"1102_CR60","doi-asserted-by":"publisher","first-page":"3925","DOI":"10.1093\/eurheartj\/ehac361","volume":"43","author":"F Kronenberg","year":"2022","unstructured":"Kronenberg F, Mora S, Stroes ESG, Ference BA, Arsenault BJ, Berglund L, et al. Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: A european atherosclerosis society consensus statement. Eur Heart J. 2022;43:3925\u201346. https:\/\/doi.org\/10.1093\/eurheartj\/ehac361.","journal-title":"Eur Heart J"},{"key":"1102_CR61","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1093\/eurheartj\/ehz310","volume":"41","author":"S Tsimikas","year":"2020","unstructured":"Tsimikas S, Gordts PLSM, Nora C, Yeang C, Witztum JL. Statin therapy increases lipoprotein(a) levels. Eur Heart J. 2020;41:2275\u201384. https:\/\/doi.org\/10.1093\/eurheartj\/ehz310.","journal-title":"Eur Heart J"},{"key":"1102_CR62","doi-asserted-by":"publisher","first-page":"e9025","DOI":"10.1097\/MD.0000000000009025","volume":"96","author":"JY Han","year":"2017","unstructured":"Han JY, Kim HJ, Shin S, Park J, Lee IG. Elevated serum lipoprotein(a) as a risk factor for combined intracranial and extracranial artery stenosis in a child with arterial ischemic stroke. Medicine. 2017;96:e9025. https:\/\/doi.org\/10.1097\/MD.0000000000009025.","journal-title":"Medicine"},{"key":"1102_CR63","doi-asserted-by":"publisher","unstructured":"Moriarty PM, Tennant HH, Sehar N, Denney L, Luna P, Perez-Marques F, et al. Case report of male child with elevated lipoprotein (a) leading to acute ischemic stroke. J Clin Apher. 2017;32. https:\/\/doi.org\/10.1002\/jca.21525.","DOI":"10.1002\/jca.21525"}],"container-title":["Current Atherosclerosis Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-023-01102-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11883-023-01102-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-023-01102-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T05:31:31Z","timestamp":1685943091000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11883-023-01102-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,9]]},"references-count":63,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["1102"],"URL":"https:\/\/doi.org\/10.1007\/s11883-023-01102-5","relation":{},"ISSN":["1523-3804","1534-6242"],"issn-type":[{"type":"print","value":"1523-3804"},{"type":"electronic","value":"1534-6242"}],"subject":[],"published":{"date-parts":[[2023,5,9]]},"assertion":[{"value":"12 April 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no potential conflicts of interest with respect to the research, authorship, and\/or publication of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}